CTI Life Sciences Fund is a limited partnership formed in 2006. The Fund make venture capital investments in high quality emerging life sciences companies at the start-up and clinical development stage primarily in Canada. This fund is the first of its kind created in Quebec since 2002.
| Company | Date | Round | Size | Participants |
| Xagenic | 1/12 | Series A | $10M | 3 |
| Zymeworks | 9/11 | Series D | $8.1M | 1 |
| Enobia Pharma | 8/09 | Series C | $50M | 4 |
| Zymeworks | 6/09 | Series C | $3.5M | 1 |
| Enobia Pharma | 8/07 | Series B | C$40.1M | 4 |
